Is Vaxfab Enterp. overvalued or undervalued?

As of 13 October 2025, Vaxfab Enterprises has seen its valuation grade change from attractive to fair. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 28.98, an EV to EBITDA of 28.06, and a ROCE of 3.34%.
In comparison with peers, Vaxfab's PE ratio is significantly lower than Elitecon International's exorbitant 360.49 and MMTC's 146.18, while it is on par with Optiemus Infra, which has a PE of 90.56. Despite its fair valuation, Vaxfab has demonstrated impressive stock performance, with a year-to-date return of 236.91%, greatly outpacing the Sensex's 5.36% during the same period.